Voice-related quality of life in T1 glottic cancer: Irradiation versus endoscopic excision

Annals of Otology, Rhinology and Laryngology

Volumn 115, Issue 8, 2006, Pages 581-586

  Cohen, Seth M ^a,d   Garrett, C Gaelyn ^a   Dupont, William D ^b   Ossoff, Robert H ^a   Courey, Mark S ^c  

^a Vanderbilt Voice Center   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NONE   (United States)

Author keywords

Glottic cancer; Meta analysis; Quality of life; Voice handicap

Indexed keywords

ADULT; AGED; BEAM THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CARBON DIOXIDE LASER; CLINICAL TRIAL; ENDOSCOPIC SURGERY; HUMAN; LARYNX CANCER; META ANALYSIS; PRIORITY JOURNAL; QUALITY OF LIFE; RANK SUM TEST; REVIEW; SCORING SYSTEM; SYSTEMATIC REVIEW; VOICE; VOICE HANDICAP INDEX; WILCOXON SIGNED RANKS TEST;

EID: 33747425956     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940611500803     Document Type: Review

References (28)

1. Kanonier G, Fritsch E, Rainer T, Thumfart WF. Radiotherapy in early glottic carcinoma. Ann Otol Rhinol Laryngol 1996;105:759-63.
2. Pellitteri PK, Kennedy TL, Vrabec DP, Beiler D, Hellstrom M. Radiotherapy. The mainstay in the treatment of early glottic carcinoma. Arch Otolaryngol Head Neck Surg 1991;117: 297-301.
3. Cragle SP, Brandenburg JH. Laser cordectomy or radio-therapy: cure rates, communication, and cost. Otolaryngol Head Neck Surg 1993;108:648-54.
4. Davis RK, Kelly SM, Parkin JL, Stevens MH, Johnson LP. Selective management of early glottic cancer. Laryngoscope 1990;100:1306-9.
5. Elner A, Fex S. Carbon dioxide laser as primary treatment of glottic T1S and T1A tumours. Acta Otolaryngol Suppl (Stockh) 1988(suppl 449):135-9.
6. Wedman J, Heimdal JH, Elstad I, Olofsson J. Voice results in patients with T1a glottic cancer treated by radiotherapy or endoscopic measures. Eur Arch Otorhinolaryngol 2002;259:547-50.
7. Simpson CB, Postma GN, Stone RE, Ossoff RH. Speech outcomes after laryngeal cancer management. Otolaryngol Clin North Am 1997;30:189-205.
8. Loughran S, Calder N, MacGregor FB, Carding P, Mac-Kenzie K. Quality of life and voice following endoscopic resection or radiotherapy for early glottic cancer. Clin Otolaryngol 2005;30:42-7.
9. Rydell R, Schalen L, Fex S, Einer A. Voice evaluation before and after laser excision vs. radiotherapy of T1A glottic carcinoma. Acta Otolaryngol (Stockh) 1995;115:560-5.
10. McGuirt WF, Blalock D, Koufman JA, et al. Comparative voice results after laser resection or irradiation of T1 vocal cord carcinoma. Arch Otolaryngol Head Neck Surg 1994;120:951-5.
11. Rovirosa A, Martinez-Celdran E, Ortega A, et al. Acoustic analysis after radiotherapy in T1 vocal cord carcinoma: a new approach to the analysis of voice quality. Int J Radiat Oncol Biol Phys 2000;47:73-9.
12. Woodson GE, Rosen CA, Murry T, et al. Assessing vocal function after chemoradiation for advanced laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 1996;122:858-64.
13. Lehman JJ, Bless DM, Brandenburg JH. An objective assessment of voice production after radiation therapy for stage I squamous cell carcinoma of the glottis. Otolaryngol Head Neck Surg 1988;98:121-9.
14. Jacobson BH, Johnson A, Grywalski C, Silbergleit A, Jacobson G, Benninger MS. The Voice Handicap Index (VHI): development and validation. Am J Speech Lang Pathol 1997;6: 66-70.
15. Peretti G, Piazza C, Balzanelli C, Mensi MC, Rossini M, Antonelli AR. Preoperative and postoperative voice in Tis-T1 glottic cancer treated by endoscopic cordectomy: an additional issue for patient counseling. Ann Otol Rhinol Laryngol 2003;112:759-63.
16. Rothman KJ, Greenland S. Modern epidemiology. 2nd ed. Philadelphia, Pa: Lippincott-Raven, 1998:660-1.
17. Brondbo K, Benninger MS. Laser resection of T1a glottic carcinomas: results and postoperative voice quality. Acta Otolaryngol (Stockh) 2004;124:976-9.
18. Peelers AJ, van Gogh CD, Goor KM, Verdonck-de Leeuw IM, Langendijk JA, Mahieu HF. Health status and voice outcome after treatment for T1a glottic carcinoma. Eur Arch Otorhinolaryngol 2004;261:534-40.
19. Behrman A, Abramson AL, Myssiorek D. A comparison of radiation-induced and presbylaryngeal dysphonia. Otolaryngol Head Neck Surg 2001;125:193-200.
20. Fung K, Yoo J, Leeper HA, et al. Vocal function following radiation for non-laryngeal versus laryngeal tumors of the head and neck. Laryngoscope 2001;111:1920-4.
21. Cohen SM, Dupont WD, Courey MS. Quality-of-life impact of non-neoplastic voice disorders: a meta-analysis. Ann Otol Rhinol Laryngol 2006;115:128-34.
22. Johns MM, Garrett CG, Hwang J, Ossoff RH, Courey MS. Quality-of-life outcomes following laryngeal endoscopic surgery for non-neoplastic vocal fold lesions. Ann Otol Rhinol Laryngol 2004;113:597-601.
23. Spector BC, Netterville JL, Billante C, Clary J, Reinisch L, Smith TL. Quality-of-life assessment in patients with unilateral vocal cord paralysis. Otolaryngol Head Neck Surg 2001; 125:176-82.
24. Benninger MS, Gardner G, Grywalski C. Outcomes of botulinum toxin treatment for patients with spasmodic dysphonia. Arch Otolaryngol Head Neck Surg 2001;127:1083-5.
25. Rosier JF, Gregoire V, Counoy H, et al. Comparison of external radiotherapy, laser microsurgery and partial laryngectomy for the treatment of T1N0M0 glottic carcinomas: a retrospective evaluation. Radiother Oncol 1998;48:175-83.
26. Urken ML, Biller HF. Management of early vocal cord carcinoma. Oncology 1988;2:48-62.
27. Benninger MS, Gillen J, Thieme P, Jacobson B, Dragovich J. Factors associated with recurrence and voice quality following radiation therapy for T1 and T2 glottic carcinomas. Laryngoscope 1994;104:294-8.
28. Zeitels SM, Hillman RE, Franco RA, Bunting GW. Voice and treatment outcome from phonosurgical management of early glottic cancer. Ann Otol Rhinol Laryngol Suppl 2002;111(suppl 190).